Resonance Health (RHT.AX) Részvény Árfolyam
Resonance Health Árfolyam
Az árbevétel évi 11,9%-kal nőtt az elmúlt 19 évben 15,75 M AUD-ra. Az egy részvényre jutó eredmény évi 3,8%-kal nőtt az elmúlt 17 évben. A(z) Resonance Health nettó árrés jelenleg 9,6%, emelkedett a néhány évvel ezelőtti -29,8%-hoz képest.
Resonance Health részvényár
Ezeket az adatokat az Eulerpool API-n keresztül
100 000 kérés/hó ingyen · nincs bankkártya
Resonance Health üzleti modell és részvényelemzés
Gyakran feltett kérdések a Resonance Health részvényről
The business model of Resonance Health Ltd focuses on providing innovative medical imaging software and services. The company aims to improve patient care and outcomes through its advanced technology solutions. Resonance Health specializes in the development and commercialization of non-invasive diagnostic tools, particularly in the field of liver and cardiac diseases. By leveraging its expertise in quantitative analysis and iron overload assessment, Resonance Health offers reliable and efficient solutions for diagnosing and managing various health conditions. The company operates by licensing its software to medical institutions and partnering with healthcare providers, ensuring widespread accessibility and utilization of its cutting-edge technologies.
Resonance Health Ltd is primarily active in the healthcare and medical technology industries.
The main competitors of Resonance Health Ltd in the market include other companies operating in the medical diagnostics and healthcare sector. Some prominent competitors are InHealth Group, Q BioMed, and Novartis AG. Resonance Health Ltd faces competition from these companies in developing innovative diagnostic solutions and providing high-quality healthcare services.
Resonance Health Ltd. is a leading provider of automated, non-invasive medical imaging software and analysis services. Founded in 1987, the company has a rich history of innovation and expertise in the field of liver and cardiac MRI imaging. Resonance Health's technology allows for accurate and reliable diagnosis of liver iron concentration and cardiac ejection fraction, essential measurements for monitoring patients with iron overload and heart conditions. With a strong commitment to research and development, Resonance Health continues to develop cutting-edge solutions that improve patient outcomes and streamline healthcare processes. As a trusted name in the industry, Resonance Health Ltd. has gained recognition globally for its advanced medical imaging products and services.
Resonance Health Ltd, a leading company in the healthcare sector, has accomplished several significant milestones. One noteworthy achievement is the development of FerriScan®, an advanced diagnostic tool for measuring liver iron concentration. Through extensive research and innovative technology, Resonance Health Ltd has revolutionized the diagnosis and monitoring of iron overload disorders such as hereditary hemochromatosis and thalassemia. The company has also expanded its global presence by establishing partnerships with renowned medical institutions and securing regulatory approvals for its groundbreaking products. With a relentless commitment to advancing patient care, Resonance Health Ltd continues to make remarkable strides in the field of medical diagnostics.
Resonance Health Ltd is primarily present in multiple countries and regions across the world. With its global reach, the company has established a strong presence in key markets. Its operations span across Australia, the United States, Europe, and Asia-Pacific regions. Resonance Health Ltd's commitment to expanding its footprint internationally has enabled it to serve a diverse range of customers and collaborate with partners on a global scale. This global presence reinforces Resonance Health Ltd's position as a leading player in the industry while allowing it to leverage various market opportunities and better serve its stakeholders.
Resonance Health Ltd represents values of innovation, excellence, and integrity in its corporate philosophy. As a leading stock health company, Resonance Health Ltd focuses on utilizing advanced technology and research to improve the diagnosis and treatment of liver diseases and iron disorders. With a dedicated team of experts, the company prioritizes accuracy and efficiency in its solutions, delivering reliable results to healthcare professionals worldwide. Resonance Health Ltd strives to enhance patient care by providing precise diagnostic tools, earning recognition for its commitment to quality and advancing medical knowledge.
Az aktuális árfolyamon a Resonance Health részvény 0,05 EUR (0,08 AUD).
A Resonance Health részvény (RHT.AX) 1 tőzsdén jegyzett, többek között: ASX (RHT.AX).
Resonance Health Ltd is a medical technology and software company specializing in the development and marketing of medical imaging devices, software, and services. The company is based in Perth, Australia, and operates worldwide.
A bevétele Resonance Health 15,75 M AUD. Ez az érték az aktuális pénzügyi adatokon alapul, és a vállalat üzleti teljesítményét tükrözi.
A nyeresége Resonance Health 1,51 M AUD. A nettó nyereség a vállalat nyereségességét tükrözi az összes költség levonása után.
A Resonance Health ár/nyereség mutatója (P/E) jelenleg 23,93. A P/E mutató az aktuális részvényárat az egy részvényre jutó nyereséggel hasonlítja össze, és segít a befektetőknek a Resonance Health részvény értékelésének megértésében.
A Resonance Health ár/értékesítés mutatója (P/S) jelenleg 2,30. A P/S mutató a piaci kapitalizációt az éves bevételhez hasonlítja, és a Resonance Health részvény értékelési mérőszámaként szolgál.
Az Eulerpool minőségi pontszáma a Resonance Health számára 5/10.
A Resonance Health ISIN-je AU000000RHT2. Az ISIN (International Securities Identification Number) a nemzetközi securities azonosító.
A Resonance Health WKN-je A0BK8V. A WKN (Wertpapierkennnummer) egy hatjegyű német értékpapír-azonosító szám.
A Resonance Health ticker-e RHT.AX. A ticker szimbólum a Resonance Health részvény tőzsdei kereskedésénél használatos.
Resonance Health részvény
Resonance Health Peer Group
Resonance Health Tőzsdei rövidítés
Resonance Health FIGI
A Resonance Health összes alapfundamentuma és mélyreható elemzése
A Resonance Health részvény Eulerpool-elemzése olyan fontos pénzügyi mutatókat tartalmaz, mint a bevétel, nyereség, P/E arány, P/S arány, EBIT, valamint információk az osztalékról. Vizsgáljuk a részvények, piaci kapitalizáció, adósság, saját tőke és kötelezettségek vonatkozásait is Resonance Health. Ha részletesebb információt keres ezekről a témákról, részletes elemzéseket kínálunk az aloldalainkon.